Mirum Pharmaceuticals Free Cash Flow (Quarterly) Insights

Mirum Pharmaceuticals Inc (MIRM)

44.76 -1.50 (-3.24%) USD | NASDAQ | Nov 15, 11:53

Free Cash Flow (Quarterly) Chart

Historical Free Cash Flow (Quarterly) Data

View and export this data back to 2019. Upgrade now.

Date	Value
June 30, 2024	-14.58M
March 31, 2024	15.20M
December 31, 2023	-21.62M
September 30, 2023	-18.22M
June 30, 2023	-17.40M
March 31, 2023	-33.82M
December 31, 2022	-34.51M
September 30, 2022	-26.04M
June 30, 2022	-20.19M
March 31, 2022	-39.67M
December 31, 2021	-52.15M

Date	Value
September 30, 2021	-34.22M
June 30, 2021	-40.20M
March 31, 2021	-25.21M
December 31, 2020	-36.31M
September 30, 2020	-17.50M
June 30, 2020	-17.05M
March 31, 2020	-18.45M
December 31, 2019	-13.76M
September 30, 2019	-15.39M
June 30, 2019	-8.017M
March 31, 2019	-2.47M

Free Cash Flow Definition

Free cash flow measures the amount of cash left over from a time period after all operational and working capital payments are made. Free cash flow is an important metric because it allows you to view the amount actual cash is available to the company. Free cash flow is also commonly used in valuation calculations like the discounted cash flow valuation model.

Read full definition.

Free Cash Flow (Quarterly) Range, Past 5 Years

-52.15M

Minimum

Dec 2021

15.20M

Maximum

Mar 2024

-24.51M

Average

-21.62M

Median

Dec 2023

Free Cash Flow (Quarterly) Benchmarks